Table 1.
The hazard ratio (HR) on survival of the most significantly differential expressed gene in IOC vs LMP
| Gene | Gene expression different in IOC vs LMP [Log (Fold Change)] | ‐Log (P value) | HR (95% CL) | Median Survival Time of low group vs high group (mo) |
|---|---|---|---|---|
| FAM83D | 3.0237 | 61.4442 | 1.720 (1.290‐2.294)*** | 66.57 vs 43.00 |
| SH2D3C | 3.2686 | 30.3251 | 1.287 (0.985‐1.683) | 57.00 vs 36.27 |
| VTCN1 | 3.0068 | 25.6068 | 0.914 (0.765‐1.094) | 48.06 vs 49.73 |
| SGCA | 3.4404 | 64.923 | 0.961 (0.803‐1.150) | 41.60 vs 45.53 |
| SNTN | −4.8272 | 64.923 | 0.842 (0.632‐1.122) | 50.03 vs 57.00 |
| FAM81B | −4.3291 | 54.622 | 0.492 (0.183‐1.321) | 54.83 vs N.A. |
| SSH2 | −4.5027 | 47.9674 | 1.029 (0.786‐1.347) | 43.93 vs 47.17 |
| AGR3 | −4.1836 | 39.0844 | 0.561 (0.419‐0.753) | 41.87 vs 77.33 |
Abbreviations: IOC, invasive epithelial ovarian cancer; LMP, low malignant potential. N.A. is the median survival time for high expression group for FAM81B is not available. ***P < 0.0001.